imiquimod has been researched along with convallatoxin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, YL; Jiang, BW; Li, YX; Liu, L; Song, ZB; Tan, LP; Wang, SY; Wang, Y; Yu, CL; Zhang, WJ | 1 |
1 other study(ies) available for imiquimod and convallatoxin
| Article | Year |
|---|---|
Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models.
Topics: Animals; Disease Models, Animal; Female; HaCaT Cells; Humans; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Necroptosis; Protein Kinases; Psoriasis; Reactive Oxygen Species; Skin; Strophanthins | 2020 |